Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2297 - 2304 of 11617 results
New York City Announces a Vaccine Mandate for All Private Employers
December 7, 2021| Blog| Viewpoint
Webinar Recording: Telehealth Regulation & Enforcement: 2021 Year in Review & 2022 Outlook
December 7, 2021| Webinar| Viewpoint
Broker and Consultant Disclosures to Group Health Plans under Division BB of the Consolidated Appropriations Act, 2021
December 6, 2021| Blog| Viewpoint
Welcome to ‘Web3.’ What’s That?
December 6, 2021| News
What’s New in 5G - December 2021
December 3, 2021| Blog| Viewpoint
Science-Based Definition Of US Waters Won't Pass In Court
December 3, 2021| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.